Insiders Have Traded Ra Medical Systems Inc. (RMED) Stock In What Way?

The stock of Ra Medical Systems Inc. (AMEX:RMED) decreased by $0.0 on Monday to $0.30, down -0.73 percent. The last five days have seen an average of 1,042,186 shares of common stock traded. 1 time new highs were reached in the current year, with a fall of -$1.2623. The average number of shares traded over the last 20 days was 1,811,592, while the average volume over the last 50 days totaled 2,365,015.

RMED stock dropped -8.89% since last month. On 05/19/22, the company’s shares reached a one-month low of $0.2570. The stock touched a high of $9.82 on 01/03/22, after rallying from a low of $0.26 in 52 weeks. The price of RMED stock has declined by -80.69% or -$1.2623 this year, reaching a new high 1 time. Still, the stock price is down -96.95% from the 52-week high.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Insider Transactions

There have been 182 days since Ra Medical Systems Inc. (RMED) last reported insider trading activity on Nov 22. On Nov 22, CFO Jackson Andrew C. sold 2,684 shares at $2.62 each. This transaction resulted in the insider making $7,032. On Nov 22, McGuire Jonathan Will sold 8,149 shares at a price of US$2.62. After the transaction, the insider now owns 66,721 shares.

Valuation Metrics

Beta for the stock is 1.54. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 414.01, the price-to-book (PB) ratio of 0.10.

Financial Health

For the three months ended December 30, Ra Medical Systems Inc.’s quick ratio was 5.10, while its current ratio was 5.40, indicating its ability to pay off its debt. Based on annual data, it had gross profit of -$1.54 million and revenue of $22000.0.

Earnings Surprise

According to Ra Medical Systems Inc.’s quarterly financial report for the quarter that ended December 30. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $10000.0, while revenues fell by -11100.0% to -$2.11 million. It was predicted that Ra Medical Systems Inc.’s quarterly earnings would be -$1.23, but it ended up being -$0.85, beating the consensus by -44.70%. EBITDA was -$5.32 million for the quarter. At the end of Ra Medical Systems Inc.’s most recent quarter ended December 30, its liabilities totaled 5.64 million, while its total debt was $2.26 million. Equity owned by shareholders amounts to $32.3 million.

Technical Picture

Here’s a quick look at Ra Medical Systems Inc.’s (RMED) price momentum from a technical perspective. As of 20 May, the RSI 9-day stood at 45.76%, suggesting the stock is Neutral, with a 79.18% historical volatility rate.

The stochastic %K and %D were 28.07% and 20.69% respectively, while the average true range (ATR) was 0.0326. Based on the 14-day stochastic reading of 30.88%, the RSI (14) reading is 42.89%. On the 9-day MACD Oscillator, the stock is at 0.0107.

Analyst Ratings

Ra Medical Systems Inc. (AMEX: RMED) was downgraded by Piper Jaffray to a a Neutral rating in its latest research report. The stock was previously rated as a an Overweight. Analysts have assigned Ra Medical Systems Inc. (RMED) an Buy rating. RMED is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 2 others recommend it as a buy.

What is RMED’s price target for the next 12 months?

The current consensus forecast for the stock is between $1.10 and $12.00, with a median target price of $6.55. In analyzing these forecasts, the average price target given by analysts for Ra Medical Systems Inc. (RMED) is $6.55.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Related Articles

174452

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam